SCHEMBL273694

SCHEMBL273694

C[Si](C)(C)N(C(N)=O)[Si](C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.35
ALOX15 P16050 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
ALDH1A1 P00352 1/20 0.31
OR51E2 Q9H255 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29761217 0.71
SCHEMBL321042 0.69 LMNA (0.33) LMNA
SCHEMBL2160280 0.69 ALDH1A1 (0.32) ALDH1A1
SCHEMBL8672835 0.67 LMNA (0.44) LMNAALOX15BLMPMP22TDP1
SCHEMBL8775960 0.67 ALOX15 (0.32) LMNAALOX15BLMPMP22
SCHEMBL3586574 0.67 LMNA (0.31) LMNA
SCHEMBL19547612 0.65
SCHEMBL21184390 0.65
SCHEMBL21633440 0.65
SCHEMBL22050834 0.63 TDP1 (0.35) LMNAALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1682 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260139200-A1 COMPOSITIONS AND METHODS FOR VAPOR PHASE SURFACE MODIFICATION FUJIFILM ELECTRONIC MAT U S A INC (US) 2026-05-21 US claimed
CN-118344845-A Surface treatment method and composition for use in the method 富士胶片电子材料美国有限公司 2024-07-16 CN claimed
EP-3602606-B1 SURFACE TREATMENT METHODS AND COMPOSITIONS THEREFOR FUJIFILM ELECTRONIC MAT USA INC (US) 2024-06-26 EP claimed
US-11508569-B2 Surface treatment compositions and methods FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2022-11-22 US claimed
EP-4017924-A1 SURFACE TREATMENT COMPOSITIONS AND METHODS FUJIFILM Electronic Materials U.S.A., Inc. (US) 2022-06-29 EP claimed
CN-114258420-A Surface treatment composition and method 富士胶片电子材料美国有限公司 2022-03-29 CN claimed
US-20210057210-A1 Surface Treatment Compositions and Methods FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. 2021-02-25 US claimed
WO-2021034491-A1 SURFACE TREATMENT COMPOSITIONS AND METHODS FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2021-02-25 WO claimed
CN-109575048-B Preparation method of cefotaxime sodium 辽宁美亚制药有限公司 2021-02-09 CN claimed
EP-3662033-A1 AMIDOAMINE SYNTHESIS, METHODS TO TRACK THE REACTION PROCESS M.I L.L, C. (US) 2020-06-10 EP claimed
EP-0298652-A2 Dehydrogenation process and intermediates MERCK & CO. INC. (US) 1989-01-11 EP claimed
EP-0248779-A1 Process for producing positive patterns in a photoresist layer U C B, S.A. (BE) 1987-12-09 EP claimed
US-4487906-A Thermosetting organopolysiloxane compositions BAYER AKTIENGESELLSCHAFT (DE) 1984-12-11 US claimed
EP-0024292-B1 PROCESS FOR THE SEPARATION OF URSODEOXYCHOLIC ACID FROM CHENODEOXYCHOLIC ACID AND PRODUCTS OBTAINED DURING THE PROCESS BLASCHIM S.p.A. (IT) 1983-06-01 EP claimed
US-4337206-A Process for preparing high purity ursodeoxycholic acid ERREGIERRE S.P.A. (IT) 1982-06-29 US claimed
US-4316848-A Process for the purification of ursodeoxycholic acid BLASINACHIM S.P.A (IT) 1982-02-23 US claimed
US-4272438-A SILYLATING, ACYLATION GLAXO GROUP LIMITED (GB) 1981-06-09 US claimed
US-4173569-A Preparation of pyrrolidine and pyrrolidin-2-one derivatives I.S.F. SPA (IT) 1979-11-06 US claimed
US-4124594-A REACTING AMINO-HYDROXYBUTYRIC ACID WITH A SILYLATING AGENT FOLLOWED BY REACTION WITH A HALOGENATED ESTER, CYCLIZATION I.S.F. SPA (IT) 1978-11-07 US claimed
US-3992428-A REACTING UREA AND HEXAMETHYLDISILAZANE IN THE PRESENCE OF A NITROGEN CONTAINING SALT WACKER-CHEMIE GMBH (DT) 1976-11-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260139200-A1 COMPOSITIONS AND METHODS FOR VAPOR PHASE SURFACE MODIFICATION DNMT1, VIL1, EPCAM LMNA 1912/4885ALOX15 3831/4885BLM 3618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.